The opioid antagonists Naloxone, Naltrexone and κ-OR agonists are used systemically and topically for the treatment of various types of chronic pruritus, e.g. in liver diseases or chronic dermatoses [8, 35–41]. The gene discussed is OPRK1; the disease is liver disorder.